Bay Area cancer-fighting startup acquired for up to $9.8B in blockbuster deal
April 28, 2016 at 09:35 AM EDT
Pharmaceutical giant AbbVie on Thursday said it will acquire South San Francisco cancer drug startup Stemcentrx in a deal that could be worth up to $9...